Alpha-Galacto-Oligosaccharides at Low Dose Improve Liver Steatosis in a High-Fat Diet Mouse Model
Non-Alcoholic Fatty Liver Disease (NAFLD) is the major liver disease worldwide and is linked to the development of metabolic syndrome and obesity. As alpha-galacto-oligosaccharides (α-GOS) from legumes have been shown to reduce body weight and hyperphagia in overweight adults, it was hypothesized th...
Main Authors: | Eric Chappuis, Fanny Morel-Depeisse, Bruno Bariohay, Julien Roux |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2017-10-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/22/10/1725 |
Similar Items
-
Galacto-oligosaccharides and colorectal cancer: Feeding our intestinal probiome
by: Jose M. Bruno-Barcena, et al.
Published: (2015-01-01) -
Infant-Associated Bifidobacterial β-Galactosidases and Their Ability to Synthesize Galacto-Oligosaccharides
by: Valentina Ambrogi, et al.
Published: (2021-05-01) -
Prebiotics for Lactose Intolerance: Variability in Galacto-Oligosaccharide Utilization by Intestinal Lactobacillus rhamnosus
by: Jason W. Arnold, et al.
Published: (2018-10-01) -
Impact of Buffering Capacity and Low Dose Galacto-Oligosaccharide on in-vitro Infant Fecal Cultures
by: Stiverson, Jill A.
Published: (2011) -
A Galacto-Oligosaccharides Preparation Derived From Lactulose Protects Against Colorectal Cancer Development in an Animal Model
by: Javier Fernández, et al.
Published: (2018-08-01)